Bioactive Capsular Polysaccharide from the Thermophilic Cyanophyte/Cyanobacterium Mastigocladus laminosus - Cytotoxic Properties

Abstract

The capsular polysaccharide produced by the thermophilic blue green alga/cyanobacterium Mastigocladus laminosus was tested for its cytotoxic activity against the A431 human epidermoid carcinoma cell line. This polysaccharide inhibited the proliferation of A431 cells in a dose-dependent manner with an IC₅₀ value of 50 μg mL^-1. In addition, this polysaccharide strongly inhibited A431 cell migration and invasion. Preliminary experiments showing that secretion of metalloproteinases MMP2 and MMP9 by A431 tumour cells was inhibited by this polysaccharide suggest that this mechanism of action could play a role in its anti-migration and anti-invasive properties. Acid hydrolysis of the polysaccharide produced specific oligosaccharides which conserved - at similar concentrations - their cytotoxic, anti-migration and anti-invasion properties; in this case, the mechanism of action was nevertheless uncorrelated to the decrease of metalloproteinase expression.

Mastigocladus laminosus - blue-green alga - cyanobacterium - capsular polysaccharide - carcinoma - cytotoxic properties

References

• 1 Gloaguen V, Krausz P. Plant polysaccharides: a biologically active class of molecules.  SOWF J. 2004;  130 20-6.
• 2 Paulsen B S. Plant polysaccharides with immunostimulatory activities.  Curr Org Chem. 2001;  5 939-50.
• 3 Skulberg O M. Microalgae as a source of bioactive molecules - experience from cyanophyte research.  J Appl Phycol. 2000;  12 341-8.
• 4 Bertocchi C, Navarini L, Cesàro A, Anastasio M. Polysaccharides from cyanobacteria.  Carbohydr Polym. 1990;  12 127-53.
• 5 Morvan H, Gloaguen V, Vebret L, Joset F, Hoffmann L. Structure-function investigations on capsular polymers as a necessary step for new biotechnological applications: the case of the cyanobacterium Mastigocladus laminosus .  Plant Physiol Biochem. 1997;  35 671-83.
• 6 De Philippis R, Vincenzini M. Exocellular polysaccharides from cyanobacteria and their possible applications.  FEMS Microbiol Rev. 1998;  22 151-75.
• 7 De Philippis R, Sili C, Paperi R, Vincenzini M. Exopolysaccharide-producing cyanobacteria and their possible exploitation: a review.  J Appl Phycol. 2001;  13 293-9.
• 8 De Philippis R, Vincenzini M. Outermost polysaccharidic investments of cyanobacteria: nature, significance and possible applications.  Recent Res Dev Microbiol. 2003;  7 13-22.
• 9 Camilios Neto C, Pinotti M HP. Cyanobacterial exopolysaccharides.  Ciéncias Exatas e Tecnológicas. 2004;  25 43-52.
• 10 Filali-Mouhim R, Hours R. Antiviral activities of sulfated polysaccharides.  Acta Bot Gall. 1995;  142 125-30.
• 11 Garbacki N, Gloaguen V, Damas J, Hoffmann L, Tits M, Angenot L. Inhibition of croton oil-induced oedema in mice ear skin by capsular polysaccharides from Cyanobacteria.  Naunyn-Schmiedeberg Arch Pharmacol. 2000;  361 460-4.
• 12 Gloaguen V, Garbacki N, Petit D, Morvan H, Hoffmann L. Bioactive capsular polysaccharide from the thermophilic Mastigocladus laminosus (Cyanophyceae/Cyanobacteria): demonstration of anti-inflammatory properties.  Arch Hydrobiol (Algological Studies). 2003;  108 63-73.
• 13 Di Benedetto M, Starzec A, Vassy R, Perret G Y, Crepin M, Kraemer M. Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative.  Br J Cancer. 2003;  88 1987-94.
• 14 Guenin E, Ledoux D, Oudar O, Lecouvey M, Kraemer M. Structure-activity relationships of a new class of aromatic bisphosphonates that inhibit tumor cell proliferation in vitro .  Anticancer Res. 2005;  25 1139-45.
• 15 Hamma-Kourbali Y, Di Benedetto M, Ledoux D, Oudar O, Leroux Y, Lecouvey M. et al . A novel non-containing-nitrogen bisphosphonate inhibits both in vitro and in vivo angiogenesis.  Biochem Biophys Res Commun. 2003;  310 816-23.
• 16 Myoken Y, Kayada Y, Okamoto T, Kan M, Sato G H, Sato J D. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.  Proc Natl Acad Sci USA. 1991;  88 5819-23.
• 17 Melnyk O, Shuman M A, Kim K J. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.  Cancer Res. 1996;  56 921-4.
• 18 Malliri A, Symons M, Hennigan R F, Hurlstone A F, Lamb R F, Wheeler T. et al . The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells.  J Cell Biol. 1998;  143 1087-99.
• 19 Mori A, Shigeki A, Furutani M, Hanaki K, Tadeka Y, Moriga T. et al . Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model.  Int J Cancer. 1999;  80 738-43.
• 20 Heissig B, Hattori K, Friedrich M, Rafii S, Werb Z. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases.  Curr Opin Hematol. 2003;  10 36-64.
• 21 Gloaguen V, Vebret L, Morvan H, Hoffmann L. Chemical composition of the capsular polymers of the blue green algal mats of the thermal spring of Néris-les-Bains.  Arch Hydrobiol Suppl (Algological Studies). 1996;  117 245-55.
• 22 Gloaguen V, Wieruszeski J M, Strecker G, Hoffmann L, Morvan H. Identification by NMR spectroscopy of oligosaccharides obtained by acidolysis of the capsular polysaccharides of a thermal biomass.  Int J Biol Macromol. 1995;  17 387-93.
• 23 Gloaguen V, Plancke Y, Strecker G, Vebret L, Hoffmann L, Morvan H. Structural characterization of three aldobiuronic acids derived from the capsular polysaccharide produced by the thermophilic cyanobacterium Mastigocladus laminosus .  Int J Biol Macromol. 1997;  21 73-9.
• 24 Gloaguen V, Morvan H, Hoffmann L, Plancke Y, Wieruszeski J M, Lippens G. et al . Capsular polysaccharide produced by the thermophilic cyanobacterium Mastigocladus laminosus : structural study of a dodecasaccharide obtained by lithium degradation.  Eur J Biochem. 1999;  266 762-70.
• 25 Moine C, Krausz P, Chaleix V, Sainte Catherine O, Kraemer M, Gloaguen V. Structural characterization and cytotoxic properties of a 4-O-methylglucuronoxylan from Castanea sativa .  J Nat Prod. 2007;  70 60-6.
• 26 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.  J Immunol Methods. 1983;  65 55-63.
• 27 Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P. et al . Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.  J Hepatol. 1997;  26 1458-66.
• 28 Witczak Z J, Kaplon P, Dey P M. Thio-sugars VII. Effect of 3-deoxy-4-S-(beta-D-gluco- and beta-D-galactopyranosyl)-4-thiodisaccharides and their sulfoxides and sulfones on the viability and growth of selected murine and human tumor cell lines.  Carbohydr Res. 2003;  338 11-8.
• 29 Mishima T, Murata J, Toyoshima M, Fujii H, Nakajima M, Hayashi T. et al . Inhibition of tumor invasion and metastasis (Ca-SP), a novel sulfated polysaccharide derived from a blue green alga, Spirulina platensis .  Clin Exp Metastasis. 1998;  16 541-50.
• 30 Lee J B, Srisomporn P, Hayashi K, Tanaka T, Snakawa U, Hayashi T. Effect of structural modification of calcium spirulan, a sulfated polysaccharide from Spirulina platensis, on antiviral activity.  Chem Pharm Bull. 2001;  49 108-10.